SMAD3 and breast angiosarcoma: We performed consensus clustering to classify BA patients in the GSE46960 dataset into two clusters: cluster 1 (low expression of SMAD3, high expression of PPARα and NR1H4) and cluster 2 (high expression of SMAD3, low expression of PPARα and NR1H4).